Plasma Services Group provides sera and other samples for materials of control reagents and calibrators for a variety of diseases.

With the registration, the analyzer can be used for clinical testing in South Korea, expanding Quanterix's reach in that country's in vitro diagnostic and clinical laboratory markets.

Last week, readers were most interested in a story about an MOU between EDX Medical Group and Spire Healthcare centered on diagnostic products and testing services.

NEW YORK – Researchers at Yale and Rutgers universities have developed a fast method to detect rare disease-causing point mutations directly from blood. Using a novel amplification technology coupled ...

Caris plans to use the proceeds from its IPO to pay off about $400 million worth of debt, he noted, and it also intends to ...

NEW YORK – Qiagen announced on Wednesday that it has launched a third-party partnering program for its clinical digital PCR platform and signed an agreement with the program's inaugural partner, South ...

NEW YORK – The US Department of Justice said Wednesday that a Chicago lab owner has been sentenced to seven years in prison for his role in a COVID-19 testing fraud scheme. During 2021 and 2022, lab ...

NEW YORK – In a letter to customers on Wednesday, Bio-Rad Laboratories announced that it has decided against implementing a tariff surcharge that the company on May 21 said it was considering for at ...

NEW YORK – Grail on Wednesday reported positive topline performance and safety results from its Pathfinder 2 study, finding that adding its multi-cancer early detection (MCED) test to standard-of-care ...